Table 1.
Baseline Demographic and Clinical Characteristics of Men Participating in STAR*D Level 1, by Inclusion Status.
Characteristic | Included, n = 387 | Excluded, n = 657 | p |
---|---|---|---|
Age at study entry, M (SD) | 44.6 (12.5) | 42.3 (12.6) | .004 |
Race, n (%) | |||
White | 303 (78.3) | 519 (79.0) | .871 |
Black or African American | 62 (16.0) | 98 (14.9) | |
Other | 22 (5.7) | 40 (6.1) | |
Hispanic, n (%) | 31 (8.0) | 58 (8.8) | .648 |
Age at onset, M (SD) | 27.3 (14.7) | 26.5 (14.2) | .394 |
Number of depressive episodes before baseline, M (SD) | 7.9 (12.8) | 6.5 (10.3) | .088 |
Depression severity (QIDS-SR16) at baseline, M (SD) | 15.3 (3.9) | 15.8 (4.0) | .059 |
Psychiatric comorbidities, n (%) | |||
Generalized anxiety disorder | 74 (19.3) | 118 (18.3) | .689 |
Posttraumatic stress disorder | 78 (20.4) | 127 (19.8) | .812 |
Bulimia | 26 (6.7) | 44 (6.8) | .973 |
Social phobia | 110 (28.8) | 182 (28.2) | .831 |
Obsessive–compulsive disorder | 44 (11.5) | 83 (12.8) | .518 |
Panic disorder | 42 (11.0) | 75 (11.6) | .753 |
Psychosis | 48 (12.5) | 103 (15.9) | .138 |
Agoraphobia | 35 (9.1) | 79 (12.2) | .129 |
Alcohol abuse/dependence | 67 (17.5) | 118 (18.2) | .789 |
Drug abuse/dependence | 38 (9.9) | 68 (10.5) | .749 |
Somatization disorder | 3 (0.8) | 7 (1.1) | .636 |
Hypochondriasis | 6 (1.6) | 29 (4.5) | .012 |
Note. STAR*D = Sequenced Treatment Alternatives to Relieve Depression; QIDS-SR16 = Quick Inventory of Depressive Symptomatology.